Stockreport

Evaxion announces business update and third quarter 2024 financial results

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF COPENHAGEN, Denmark, October 31, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powere [Read more]